- Home
- ELVN vs GPGI Comparison
ELVN vs GPGI Comparison
Compare ELVN & GPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$54.32
Company Overview
Basic Information| Metric | ELVN | GPGI |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.8B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ELVN | GPGI |
|---|---|---|
| Price | $54.32 | $13.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $43.40 | N/A |
| AVG Volume (30 Days) | 783.2K | ★ 1.6M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.07% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $59,824,000.00 |
| Revenue This Year | N/A | $768.10 |
| Revenue Next Year | N/A | $126.25 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.79 | $11.22 |
| 52 Week High | $62.32 | $25.66 |
Technical Indicators
Market Signals| Indicator | ELVN | GPGI |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 43.71 |
| Support Level | $25.63 | $12.70 |
| Resistance Level | $62.16 | $13.07 |
| Average True Range (ATR) | 1.95 | 0.66 |
| MACD | -0.59 | 0.04 |
| Stochastic Oscillator | 1.93 | 29.06 |
Price Performance
Historical Comparison ELVN
GPGI
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About GPGI GPGI Inc.
GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.